Hemogenyx Pharmaceuticals Share Discussion Threads

[jaknife] 08/1/2025 10:20

Pangrati,

"One institutional investor has subscribed for the Placing Shares"

Which translates as: a market-maker has being selling (short) to punters for a while and has now subscribed for shares to cover their short.

JakNife

[pangrati] 08/1/2025 08:50

One institutional investor has subscribed for the Placing Shares

[trader4ever] 08/1/2025 08:32

Vlad has been deceiving shareholder for many years, most of that money raised for the last 5 years has been used to pay high salaries for the highly incompetent management.

Vlad is a deceiver, just look at the share price, what value has he delivered for the shareholders in the last 5 years.

[terminator101] 08/1/2025 07:49

Mad vlad strikes again huh. When will the gerbils learn?

[pangrati] 08/1/2025 07:40

Hemogenyx Pharmaceuticals plc (LSE: HEMO) is pleased to announce that it has raised £340,000 through the issue of 100,000 new ordinary shares ("Placing Shares") at a price of 340p per share (the "Placing"). One institutional investor has subscribed for the Placing Shares and has also been granted 50,000 warrants exercisable at a price of 500p each for a period of 12 months from 1 March 2025.

The Placing uses the Company's current headroom to issue ordinary shares for cash. The net proceeds of the Placing will be dedicated to the clinical trial of the Company's lead asset, HG-CT-1, targeting relapsed/refractory (R/R) acute myeloid leukemia (AML) in adults. The first patient for the trial is recruited and being tested for inclusion/exclusion criteria to satisfy the clinical protocol. The funds raised will also assist the Company into the next stage of the trials.

An application is being made to the Main Market of the London Stock Exchange, and admission of the Placing Shares to trading is expected on or around 15 January 2025 ("Admission"). The Placing Shares will rank pari passu with the Company's existing Ordinary Shares.


Total Voting Rights

For the purpose of the Disclosure Guidance and Transparency Rules, following Admission the enlarged issued share capital of the Company will comprise 3,604,539 ordinary shares. The Company does not hold any shares in treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure Guidance and Transparency Rules.

[pangrati] 08/1/2025 07:38

Hemogenyx Pharmaceuticals plc (LSE: HEMO) is pleased to announce that it has raised £340,000 through the issue of 100,000 new ordinary shares ("Placing Shares") at a price of 340p per share (the "Placing"). One institutional investor has subscribed for the Placing Shares and has also been granted 50,000 warrants exercisable at a price of 500p each for a period of 12 months from 1 March 2025.

The Placing uses the Company's current headroom to issue ordinary shares for cash. The net proceeds of the Placing will be dedicated to the clinical trial of the Company's lead asset, HG-CT-1, targeting relapsed/refractory (R/R) acute myeloid leukemia (AML) in adults. The first patient for the trial is recruited and being tested for inclusion/exclusion criteria to satisfy the clinical protocol. The funds raised will also assist the Company into the next stage of the trials.

An application is being made to the Main Market of the London Stock Exchange, and admission of the Placing Shares to trading is expected on or around 15 January 2025 ("Admission"). The Placing Shares will rank pari passu with the Company's existing Ordinary Shares.


Total Voting Rights

For the purpose of the Disclosure Guidance and Transparency Rules, following Admission the enlarged issued share capital of the Company will comprise 3,604,539 ordinary shares. The Company does not hold any shares in treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure Guidance and Transparency Rules.

[ashleyjv] 23/12/2024 15:37

I bought a few more today (A couple of hours ago) and it's still not showing

[loglorry1] 19/12/2024 07:47

Pathetic attempt to save the share price today. Huge rinse coming.

[penrith] 17/12/2024 11:01

Was looking at investing here but completely put off by the youtube interview. Extremely unconvincing presentation particularly by the couldnt care or less attitude by the guy in the sweater. The science may be good but I cant see those two attracting any seriouse investment. Have either a proven track record in business?
Its a real shame as I am very attracted by the project.

[luckyabbeygale] 17/12/2024 11:00

Jackknife is coining it in again.Follow him and you will always be rich.

[bloomberg2] 17/12/2024 10:11

Low liquidity main course of drop ! Future Funding is a concern! Good partnership rns will see it fly may be

[bloomberg2] 17/12/2024 10:09

It's being played

[bones698] 17/12/2024 08:18

Not long at the rate it's going . Talk about one to short

[icejelly] 16/12/2024 16:26

How long before this gets back down to 1p?

[lean5gb] 13/12/2024 12:14

Im in at 250p.... I have the patience, but,...... It'll not be a long wait .. :0)))

[johnpope] 13/12/2024 09:21

This is done for No one will buy

[luckyabbeygale] 13/12/2024 08:17

Now equivalent to 0.9p.

[luckyabbeygale] 11/12/2024 11:18

JackNife's pockets are endless and his shorts are hammering the price and the company will be forced to do a 0.5p placing.Without JackNife this would of never gone to 1p and the placing would of been at a premium and my bet would of never been stopped out and now I be showing a huge profit. JackNife is what keeps the spread bet company's happy.

[luckyabbeygale] 11/12/2024 09:14

You can see how JackNife shorts always wins since he keeps on increasing huge shorting trades to force the price down.

[luckyabbeygale] 10/12/2024 15:32

It makes sense how I get such a buzz out of trolling JackNife in every way I can. One thing people hate to see is someone having such success and I feel the same and especially when it is out of the misery of shorting peoples dreams.

[luckyabbeygale] 10/12/2024 15:02

Looks like 0.5p at Hemo in the short term. I wonder what JackNife profits margin will look like then.